Axogen Inc logo

Axogen Inc

$ 10.40 -0.78 (-6.98%) 10:08 PM EST
P/E:
At Loss
P/B:
4.33
Market Cap:
$ 439.78M
Enterprise V:
$ 454.32M
Volume:
185.96K
Avg Vol (2M):
221.47K
Also Trade In:
Volume:
185.96K
Market Cap $:
439.78M
PE Ratio:
At Loss
Avg Vol (2-Month):
221.47K
Enterprise Value $:
454.32M
PB Ratio:
4.33
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically proven and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other countries.
Name Current Vs Industry Vs History
Cash-To-Debt 0.79
Equity-to-Asset 0.52
Debt-to-Equity 0.67
Debt-to-EBITDA -2.89
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.68
Distress
Grey
Safe
Beneish M-Score -2.53
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.66
9-Day RSI 34.05
14-Day RSI 39.25
6-1 Month Momentum % 14.81
12-1 Month Momentum % 16.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.35
Quick Ratio 3.54
Cash Ratio 2.26
Days Inventory 273.77
Days Sales Outstanding 52.89
Days Payable 99.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4

Financials (Next Earnings Date:2023-02-21 Est.)

AXGN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AXGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 133.957
EPS (TTM) ($) -0.67
Beta 0.47
Volatility % 66.74
14-Day RSI 39.25
14-Day ATR ($) 0.663914
20-Day SMA ($) 11.5055
12-1 Month Momentum % 16.37
52-Week Range ($) 6.87 - 13.66
Shares Outstanding (Mil) 42.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Axogen Inc Filings

Document Form Filing Date
No Filing Data

Axogen Inc Analysis

Share your research

Headlines

See More
No news.